Literature DB >> 1825698

Cloning and expression of cDNA for a human thromboxane A2 receptor.

M Hirata1, Y Hayashi, F Ushikubi, Y Yokota, R Kageyama, S Nakanishi, S Narumiya.   

Abstract

Thromboxane A2 is a very unstable arachidonate metabolite, yet a potent stimulator of platelet aggregation and a constrictor of vascular and respiratory smooth muscles. It has been implicated as a mediator in diseases such as myocardial infarction, stroke and bronchial asthma. Using a stable analogue of this compound we recently purified the human platelet thromboxane A2 receptor to apparent homogeneity. Using an oligonucleotide probe corresponding to its partial amino-acid sequence, we have obtained a complementary DNA clone encoding this receptor from human placenta and a partial clone from cultured human megakaryocytic leukaemia cells. The placenta cDNA encodes a protein of 343 amino acids with seven putative transmembrane domains. The protein expressed in COS-7 cells binds drugs with affinities identical to those of the platelet receptor, and that in Xenopus oocytes opens Ca2(+)-activated Cl- channel on agonist stimulation. Northern blot analysis and nucleotide sequences of the two clones suggest that an identical species of the thromboxane A2 receptor is present in platelets and vascular tissues. This first report on the molecular structure of an eicosanoid receptor will promote the molecular pharmacology and pathophysiology of these bioactive compounds.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1825698     DOI: 10.1038/349617a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  102 in total

Review 1.  Cyclooxygenase-2 and thromboxane synthase in non-endocrine and endocrine tumors: a review.

Authors:  Onder Onguru; Mary B Casey; Sabine Kajita; Nobuki Nakamura; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  A profile of the residues in the second extracellular loop that are critical for ligand recognition of human prostacyclin receptor.

Authors:  Feng Ni; Shui-Ping So; Vanessa Cervantes; Ke-He Ruan
Journal:  FEBS J       Date:  2007-11-27       Impact factor: 5.542

3.  Lead compound design for TPR/COX dual inhibition.

Authors:  Abhay Krishna; Arpita Yadav
Journal:  J Mol Model       Date:  2012-05-16       Impact factor: 1.810

Review 4.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

5.  Coagulation defects and altered hemodynamic responses in mice lacking receptors for thromboxane A2.

Authors:  D W Thomas; R B Mannon; P J Mannon; A Latour; J A Oliver; M Hoffman; O Smithies; B H Koller; T M Coffman
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

6.  G proteins of the G12 family are activated via thromboxane A2 and thrombin receptors in human platelets.

Authors:  S Offermanns; K L Laugwitz; K Spicher; G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-18       Impact factor: 11.205

7.  Vasoreactivity of chorionic plate arteries in response to vasoconstrictors produced by preeclamptic placentas.

Authors:  C Benoit; J Zavecz; Y Wang
Journal:  Placenta       Date:  2006-10-27       Impact factor: 3.481

8.  Epidermal-growth-factor receptor and metalloproteinases mediate thromboxane A2-dependent extracellular-signal-regulated kinase activation.

Authors:  Carole Gallet; Stéphanie Blaie; Sylviane Lévy-Toledano; Aïda Habib
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

9.  Characterization of endothelial thromboxane receptors in rabbit aorta.

Authors:  Sandra L Pfister
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-09-02       Impact factor: 3.072

10.  Liver kinase B1 is required for thromboxane receptor-dependent nuclear factor-κB activation and inflammatory responses.

Authors:  Jinlong He; Yanhong Zhou; Junjie Xing; Qilong Wang; Huaiping Zhu; Yi Zhu; Ming-Hui Zou
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-28       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.